(Q42959296)
Statements
1 reference
Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET. (English)
1 reference
1 reference
Bernard Escudier
1 reference
Cezary Szczylik
1 reference
Thomas E Hutson
1 reference
Joaquim Bellmunt
1 reference
Michael Staehler
1 reference
Andrea Nadel
1 reference
Sibyl Anderson
1 reference
Ronald Bukowski
1 reference
Tim Eisen
1 reference
Sorafenib TARGET Clinical Trial Group
1 reference
23 July 2010
1 reference
1 reference
46
1 reference
13
1 reference
2432-2440
1 reference
Identifiers
1 reference
1 reference